大洋生物
(003017)
| 流通市值：18.93亿 | | | 总市值：22.86亿 |
| 流通股本：8348.11万 | | | 总股本：1.01亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 558,889,838.38 | 278,128,254.27 | 1,045,439,587.88 | 747,305,412.73 |
| 营业总成本 | 505,222,175.56 | 247,566,318.08 | 941,878,108.45 | 668,570,639.15 |
| 其他经营收益 | | | | |
| 营业利润 | 63,278,721.9 | 34,799,019.78 | 110,172,131.19 | 83,864,571.53 |
| 利润总额 | 63,311,457.64 | 34,759,597.88 | 106,851,455.43 | 82,080,424.17 |
| 净利润 | 56,923,087.19 | 30,903,872.25 | 100,064,311.65 | 79,659,043.97 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 56,923,087.19 | 30,903,872.25 | 100,064,311.65 | 79,659,043.97 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 736,578,491.77 | 797,844,290.52 | 771,313,142.89 | 742,823,347.91 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,238,030,977.39 | 1,081,084,556.54 | 1,047,144,418.45 | 1,009,976,212.88 |
| 资产总计 | 1,974,609,469.16 | 1,878,928,847.06 | 1,818,457,561.34 | 1,752,799,560.79 |
| 流动负债: | | | | |
| 流动负债合计 | 735,135,439.52 | 651,234,923.44 | 632,575,935.56 | 606,004,792.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 63,215,008.51 | 55,497,440.96 | 49,139,714.59 | 44,812,225.45 |
| 负债合计 | 798,350,448.03 | 706,732,364.4 | 681,715,650.15 | 650,817,017.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,171,706,192.39 | 1,167,064,277.25 | 1,131,642,825.85 | 1,097,470,934.09 |
| 股东权益合计 | 1,176,259,021.13 | 1,172,196,482.66 | 1,136,741,911.19 | 1,101,982,543.08 |
| 负债和股东权益合计 | 1,974,609,469.16 | 1,878,928,847.06 | 1,818,457,561.34 | 1,752,799,560.79 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 525,407,943.19 | 221,952,789.14 | 1,018,861,690.33 | 694,119,921.74 |
| 经营活动现金流出小计 | 473,782,157.74 | 225,149,740.38 | 858,755,780.34 | 580,339,698.64 |
| 经营活动产生的现金流量净额 | 51,625,785.45 | -3,196,951.24 | 160,105,909.99 | 113,780,223.1 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 10,574,478.21 | 10,117,207.24 | 159,785,143.88 | 89,300,130.18 |
| 投资活动现金流出小计 | 170,102,208.14 | 42,633,462.77 | 188,684,580.27 | 92,826,614.66 |
| 投资活动产生的现金流量净额 | -159,527,729.93 | -32,516,255.53 | -28,899,436.39 | -3,526,484.48 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 427,993,800 | 215,000,000 | 631,921,917.34 | 574,877,959.96 |
| 筹资活动现金流出小计 | 368,548,617.76 | 165,288,404.91 | 674,733,654.07 | 595,186,991.01 |
| 筹资活动产生的现金流量净额 | 59,445,182.24 | 49,711,595.09 | -42,811,736.73 | -20,309,031.05 |
| 汇率变动对现金及现金等价物的影响 | -1,469,680.09 | -962,776.98 | -232,637.5 | 698,390.46 |
| 现金及现金等价物净增加额 | -49,926,442.33 | 13,035,611.34 | 88,162,099.37 | 90,643,098.03 |
| 期末现金及现金等价物余额 | 385,480,097.2 | 448,442,150.87 | 435,406,539.53 | 437,887,538.19 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -49,926,442.33 | - | 88,162,099.37 | - |
最新报告期：2026-08-24| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 开源证券 | 蒋跨跃,金益腾 | 1.66 | 2.19 | 2.40 | 2026-08-24 |